Effectiveness of cognitive behavioral therapy for harmful cannabis use: a systematic review and meta-analysis
Open Access
- 17 February 2026
- journal article
- review article
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- p. 1-21
Abstract
This systematic review and meta-analysis evaluated the effectiveness of cognitive behavioral therapy (CBT) for cannabis use. Randomized controlled trials (RCTs) assessing CBT for cannabis use were systematically searched in MEDLINE, PsycINFO, CINAHL, AMED, Cochrane Library, and clinical trial registries. Quality of the studies were appraised using the Cochrane Risk of Bias tool (RoB1). A total of 2347 records were screened, of which nine RCTs involving 1280 participants were eligible for inclusion. Meta-analysis results showed that CBT didn't produce significant reductions in cannabis use frequency, compared with contingency management, treatment as usual and other psychosocial interventions. The pooled estimates were 0.12 (95% Confidence Interval [CI]: -0.02, 0.26; p=0.10) in short-term, -0.03 (95% CI: -0.18, 0.13; p=0.75) medium-term, and 0.01 (95% CI: -0.18, 0.20; p=0.91) long-term follow-ups. Daily cannabis consumption outcomes were inconsistent, showing a significant medium-term effect (-0.50; 95% CI: -0.90, -0.10; p<0.05) but insignificant effects at other time points. Limitations included study heterogeneity, small sample sizes, and risk of bias. Findings highlight the need for standardized CBT content, integrated with adjunctive therapies, to enhance treatment outcomes for individuals with cannabis use.Keywords
Funding Information
- CogNitive Therapy for DepRessiOn in TubercuLosis patients
- National Institute for Health and Care Research (NIHR201773)
This publication has 84 references indexed in Scilit:
- Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis LegalizationJAMA Network Open, 2025
- Effectiveness of cannabis use and cannabis use disorder interventions: a European and international data synthesisEuropean Archives of Psychiatry and Clinical Neuroscience, 2024
- Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990–2019: Results from the Disease Burden Study 2019International Journal of Mental Health and Addiction, 2023
- Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment StudyAIDS and Behavior, 2022
- Is legalization of recreational cannabis associated with levels of use and cannabis use disorder among youth in the United States? A rapid systematic reviewEuropean Child & Adolescent Psychiatry, 2022
- Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents2019
- Cannabis and mental illness: a reviewEuropean Archives of Psychiatry and Clinical Neuroscience, 2018
- Psychosocial interventions for cannabis use disorderCochrane Database of Systematic Reviews, 2016
- Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based studySocial Psychiatry and Psychiatric Epidemiology, 2015
- Converting Among Effect Sizes2009